Ischemia Modified Albumin: A Recent Biomarker in the Diagnosis of Acute Coronary Syndrome

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2018, Vol 6, Issue 7

Abstract

To identify the role of Ischemia Modified Albumin (IMA) as a cardiac biomarker in the early diagnosis of Acute Coronary Syndrome (ACS). A study was done including 40 Acute Coronary Syndrome patients (Group 2) and 40 age sex matched controls (Group 1). Blood samples were estimated for Ischemia Modified Albumin, Troponin T, CK-MB, glucose, urea, creatinine and albumin. Stastical analysis was done using SPSS version 16. Serum IMA levels and CK-MB levels were significantly increased in ACS patients when compared to the controls and they were positively correlated. No significant difference was observed in serum Albumin levels among the groups. Sensitivity of IMA was increased when used in combination with other markers like CK-MB and cTnT in the diagnosis of ACS. From our study, Ischemia Modified Albumin is a sensitive cardiac biomarker to detect myocardial ischemia and is more helpful in identifying patients with unstable angina when compared to other routine biomarkers. The serum levels of IMA and CK-MB are significantly elevated in ACS patients, when compared to the healthy controls. The combination of these markers had better sensitivity in identifying patients with ACS. Cardiovascular diseases are the leading causes of morbidity and mortality. Newer technologies have been developed in the past few decades to monitor cardiovascular disease more efficiently. Discovery of biochemical markers such as troponin I, troponin T etc help to measure myocardial damage. The majority of the markers detect only the end stage of the disease. Serum IMA, a marker of ischemia can be used for the diagnosis of early stage of ACS, that in turn could help in designing treatment modalities to reduce the morbidity and mortality associated with myocardial infarction (MI).

Authors and Affiliations

Dr. P. Kughapriya, Dr. D. Ponnudhali M. D

Keywords

Related Articles

Evaluation of Prognostic significance of TF, and β3 integrin by using Immunoflourecent staining method

Angiogenesis, the formation of new blood vessels from pre-existing ones, is enhanced in various pathological conditions including rheumatoid arthritis, diabetic retinopathy, and cancer development. Angiogenic processes a...

To Evaluate the Effect of Prewarming in Prevention of Inadvertant Peri-Operative Hypothermia and Shivering

Abstract: Core temperature is closely maintained physiological parameters as enzyme systems in the body have narrow temperature changes in which they function optimally. Inadvertant perioperative hypothermia (core temper...

Efficacy of Bupivacaine with 8 mg Dexamethasone as an adjuvant for Supraclavicular Brachial Plexus Block by comparing with 0.25%

Peripheral nerve blocks came into rise now-a-days because of more advantages on general anesthesia. Steroids are in use as an adjuvant for local anesthetics since many years, as steroids have the effects of anti-inflamma...

Alginate stability during a time

Abstract: Alginate impression materials are most commonly used materials to take preliminary impression during the prosthetic treatment. They have several advantages, like hydrophilic properties during the contact with s...

Microbiological Stydy of Diarrhoeal Patients Admitted in Tertiary Hospital of Telangana

Acute diarrhoeal illness is common in tropical regions during summer and monsoon seasons microbial agents causing diarrhea can be bacteria, virus, parasite or fungus. Our aim was to study the microbiological agents invol...

Download PDF file
  • EP ID EP475408
  • DOI -
  • Views 54
  • Downloads 0

How To Cite

Dr. P. Kughapriya, Dr. D. Ponnudhali M. D (2018). Ischemia Modified Albumin: A Recent Biomarker in the Diagnosis of Acute Coronary Syndrome. Scholars Journal of Applied Medical Sciences, 6(7), 2691-2696. https://europub.co.uk/articles/-A-475408